190 related articles for article (PubMed ID: 9445345)
21. Neuroprotection by the stable nitroxide Tempol during reperfusion in a rat model of transient focal ischemia.
Rak R; Chao DL; Pluta RM; Mitchell JB; Oldfield EH; Watson JC
J Neurosurg; 2000 Apr; 92(4):646-51. PubMed ID: 10761655
[TBL] [Abstract][Full Text] [Related]
22. Isoflurane and pentobarbital reduce the frequency of transient ischemic depolarizations during focal ischemia in rats.
Patel PM; Drummond JC; Cole DJ; Kelly PJ; Watson M
Anesth Analg; 1998 Apr; 86(4):773-80. PubMed ID: 9539600
[TBL] [Abstract][Full Text] [Related]
23. Aminoguanidine ameliorates and L-arginine worsens brain damage from intraluminal middle cerebral artery occlusion.
Zhang F; Casey RM; Ross ME; Iadecola C
Stroke; 1996 Feb; 27(2):317-23. PubMed ID: 8571430
[TBL] [Abstract][Full Text] [Related]
24. The competitive NMDA antagonist MDL-100,453 reduces infarct size after experimental stroke.
Hasegawa Y; Fisher M; Baron BM; Metcalf G
Stroke; 1994 Jun; 25(6):1241-4; discussion 1245-6. PubMed ID: 8202987
[TBL] [Abstract][Full Text] [Related]
25. A combined treatment with tacrolimus (FK506) and recombinant tissue plasminogen activator for thrombotic focal cerebral ischemia in rats: increased neuroprotective efficacy and extended therapeutic time window.
Maeda M; Furuichi Y; Ueyama N; Moriguchi A; Satoh N; Matsuoka N; Goto T; Yanagihara T
J Cereb Blood Flow Metab; 2002 Oct; 22(10):1205-11. PubMed ID: 12368659
[TBL] [Abstract][Full Text] [Related]
26. Delayed systemic administration of PACAP38 is neuroprotective in transient middle cerebral artery occlusion in the rat.
Reglodi D; Somogyvari-Vigh A; Vigh S; Kozicz T; Arimura A
Stroke; 2000 Jun; 31(6):1411-7. PubMed ID: 10835464
[TBL] [Abstract][Full Text] [Related]
27. Effect of delayed albumin hemodilution on infarction volume and brain edema after transient middle cerebral artery occlusion in rats.
Belayev L; Busto R; Zhao W; Clemens JA; Ginsberg MD
J Neurosurg; 1997 Oct; 87(4):595-601. PubMed ID: 9322848
[TBL] [Abstract][Full Text] [Related]
28. Attenuation of delayed neuronal death after mild focal ischemia in mice by inhibition of the caspase family.
Endres M; Namura S; Shimizu-Sasamata M; Waeber C; Zhang L; Gómez-Isla T; Hyman BT; Moskowitz MA
J Cereb Blood Flow Metab; 1998 Mar; 18(3):238-47. PubMed ID: 9498840
[TBL] [Abstract][Full Text] [Related]
29. Effects of ifenprodil, a polyamine site NMDA receptor antagonist, on reperfusion injury after transient focal cerebral ischemia.
Doğan A; Rao AM; Başkaya MK; Rao VL; Rastl J; Donaldson D; Dempsey RJ
J Neurosurg; 1997 Dec; 87(6):921-6. PubMed ID: 9384405
[TBL] [Abstract][Full Text] [Related]
30. Neuroprotective effect of SolCD39, a novel platelet aggregation inhibitor, on transient middle cerebral artery occlusion in rats.
Belayev L; Khoutorova L; Deisher TA; Belayev A; Busto R; Zhang Y; Zhao W; Ginsberg MD
Stroke; 2003 Mar; 34(3):758-63. PubMed ID: 12624304
[TBL] [Abstract][Full Text] [Related]
31. Postischemic administration of AK275, a calpain inhibitor, provides substantial protection against focal ischemic brain damage.
Bartus RT; Baker KL; Heiser AD; Sawyer SD; Dean RL; Elliott PJ; Straub JA
J Cereb Blood Flow Metab; 1994 Jul; 14(4):537-44. PubMed ID: 8014200
[TBL] [Abstract][Full Text] [Related]
32. Combination drug therapy and mild hypothermia after transient focal cerebral ischemia in rats.
Zausinger S; Schöller K; Plesnila N; Schmid-Elsaesser R
Stroke; 2003 Sep; 34(9):2246-51. PubMed ID: 12893947
[TBL] [Abstract][Full Text] [Related]
33. Oxyresveratrol (trans-2,3',4,5'-tetrahydroxystilbene) is neuroprotective and inhibits the apoptotic cell death in transient cerebral ischemia.
Andrabi SA; Spina MG; Lorenz P; Ebmeyer U; Wolf G; Horn TF
Brain Res; 2004 Aug; 1017(1-2):98-107. PubMed ID: 15261105
[TBL] [Abstract][Full Text] [Related]
34. Mexiletine and magnesium independently, but not combined, protect against permanent focal cerebral ischemia in Wistar rats.
Lee EJ; Ayoub IA; Harris FB; Hassan M; Ogilvy CS; Maynard KI
J Neurosci Res; 1999 Nov; 58(3):442-8. PubMed ID: 10518118
[TBL] [Abstract][Full Text] [Related]
35. The calmodulin antagonist trifluoperazine in transient focal brain ischemia in rats. Anti-ischemic effect and therapeutic window.
Kuroda S; Nakai A; Kristían T; Siesjö BK
Stroke; 1997 Dec; 28(12):2539-44. PubMed ID: 9412646
[TBL] [Abstract][Full Text] [Related]
36. Postischemic (6-Hour) treatment with recombinant human tissue plasminogen activator and proteasome inhibitor PS-519 reduces infarction in a rat model of embolic focal cerebral ischemia.
Zhang L; Zhang ZG; Zhang RL; Lu M; Adams J; Elliott PJ; Chopp M
Stroke; 2001 Dec; 32(12):2926-31. PubMed ID: 11739997
[TBL] [Abstract][Full Text] [Related]
37. Steady plasma concentration of unfractionated heparin reduces infarct volume and prevents inflammatory damage after transient focal cerebral ischemia in the rat.
Cervera A; Justicia C; Reverter JC; Planas AM; Chamorro A
J Neurosci Res; 2004 Aug; 77(4):565-72. PubMed ID: 15264226
[TBL] [Abstract][Full Text] [Related]
38. Effect of basic fibroblast growth factor on experimental focal ischemia studied by diffusion-weighted and perfusion imaging.
Tatlisumak T; Takano K; Carano RA; Fisher M
Stroke; 1996 Dec; 27(12):2292-7; discussion 2298. PubMed ID: 8969796
[TBL] [Abstract][Full Text] [Related]
39. Administration of N-acetylcysteine after focal cerebral ischemia protects brain and reduces inflammation in a rat model of experimental stroke.
Khan M; Sekhon B; Jatana M; Giri S; Gilg AG; Sekhon C; Singh I; Singh AK
J Neurosci Res; 2004 May; 76(4):519-27. PubMed ID: 15114624
[TBL] [Abstract][Full Text] [Related]
40. Relationship between the neuroprotective effect of Na+/H+ exchanger inhibitor SM-20220 and the timing of its administration in a transient middle cerebral artery occlusion model of rats.
Horikawa N; Kuribayashi Y; Matsui K; Ohashi N
Biol Pharm Bull; 2001 Jul; 24(7):767-71. PubMed ID: 11456115
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
